Targets tissue healing, gut integrity, joint recovery, and inflammation
The SURMOUNT-1 trial reported -22.5% weight reduction at the 15 mg weekly dose across 72 weeks (PMID 35658024)
In preclinical research environments, the individual components of REGENO Cartalax + TB-500 + BPC-157 have been studied for their interaction with nitric oxide-associated pathways, angiogenic signaling networks, cytoskeletal organization mechanisms, extracellular matrix-associated processes, and chondrocyte-related signaling systems
But if longevity experts and biohackers are right (and based on patient results were seeing at our centers), this isnt just wishful thinking
demonstrated that BPC-157 activates the FAK-paxillin pathway in tendon fibroblasts, directly stimulating collagen synthesis at rates 4060% above control groups